Cyfuse Biomedical K.K. Logo

Cyfuse Biomedical K.K.

4892 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
港区三田3−5−27 住友不動産三田ツインビル西館
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cyfuse Biomedical K.K. is a pioneering Japanese company specializing in innovative bioprinting technologies. Based in Tokyo with an additional office in Fukuoka, Cyfuse focuses on the development of advanced tissue engineering solutions, utilizing its proprietary 3D bioprinting platform. The company aims to revolutionize regenerative medicine by creating functional, living tissues for therapeutic applications, including drug testing and personalized medicine. With a commitment to research and development, Cyfuse Biomedical is at the forefront of transforming healthcare solutions and addressing critical challenges in tissue regeneration. Through its cutting-edge technology, Cyfuse is poised to make a significant impact on the future of medical treatments.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Cyfuse Biomedical K.K. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-14 08:31
Regulatory News Service
確認書
Japanese 9.0 KB
2025-08-14 08:30
Interim Report
半期報告書-第16期(2025/01/01-2025/12/31)
Japanese 359.3 KB
2025-05-30 08:30
Prospectus
有価証券届出書(組込方式)
Japanese 924.1 KB
2025-03-26 03:03
Regulatory News Service
臨時報告書
Japanese 21.4 KB
2025-03-26 03:02
Regulatory News Service
内部統制報告書-第15期(2024/01/01-2024/12/31)
Japanese 22.7 KB
2025-03-26 03:01
Annual Report
有価証券報告書-第15期(2024/01/01-2024/12/31)
Japanese 2.2 MB
2025-03-26 03:01
Regulatory News Service
確認書
Japanese 9.0 KB
2025-02-25 08:30
Regulatory News Service
臨時報告書
Japanese 20.6 KB
2024-08-14 08:33
Regulatory News Service
確認書
Japanese 9.0 KB
2024-08-14 08:32
Interim Report
半期報告書-第15期(2024/01/01-2024/12/31)
Japanese 234.3 KB
2024-05-15 09:16
Regulatory News Service
確認書
Japanese 9.0 KB
2024-05-15 09:15
Quarterly Report
四半期報告書-第15期第1四半期(2024/01/01-2024/03/31)
Japanese 196.4 KB
2024-04-17 10:10
Regulatory News Service
臨時報告書
Japanese 43.2 KB
2024-03-27 08:18
Regulatory News Service
臨時報告書
Japanese 23.2 KB
2024-03-27 08:17
Regulatory News Service
内部統制報告書-第14期(2023/01/01-2023/12/31)
Japanese 22.8 KB

Automate Your Workflow. Get a real-time feed of all Cyfuse Biomedical K.K. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Cyfuse Biomedical K.K. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Diasorin Logo
Develops immunodiagnostic and molecular diagnostic kits and systems for healthcare and research.
Italy DIA
Dottikon ES Holding AG Logo
Exclusive synthesis of APIs & fine chemicals via hazardous reactions for pharma/biotech industries.
Switzerland DESN
Double Bond Pharmaceutical International AB Logo
Redeveloping drugs with proprietary delivery tech for oncology & infectious diseases.
Sweden DBP B
ECO ANIMAL HEALTH GROUP PLC Logo
Develops pharmaceuticals for respiratory & enteric diseases in global swine and poultry markets.
United Kingdom EAH
Ectin Research AB Logo
Clinical-stage biotech developing novel cancer treatments, focusing on metastatic bladder cancer.
Sweden ECTIN B
Eevia Health Plc Logo
Manufactures validated polyphenol extracts from Arctic plants for the supplement & food industries.
Finland EEVIA
Egetis Therapeutics Logo
Develops and commercializes drugs for serious rare diseases with unmet medical needs.
Sweden EGTX
EIKEN CHEMICAL CO.,LTD. Logo
Manufacturer of clinical diagnostics, specializing in FIT systems for cancer and microbiological tests.
Japan 4549
Eisai Co., Ltd. Logo
A global, research-based pharmaceutical firm that develops and markets prescription and OTC drugs.
Japan 4523
Elicera Therapeutics AB Logo
Develops CAR T-cell & oncolytic virus therapies for cancer, enhanced by its iTANK platform.
Sweden ELIC

Talk to a Data Expert

Have a question? We'll get back to you promptly.